Acadia and Neuren revenues are tied in particular to insurance companies paying for patient treatments My concern relates to the business risk associated with possible resistance by insurance companies to paying for treatments without a clear mechanism of action.
Kens
Share Price, page-10105
-
- There are more pages in this discussion • 1,578 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.92 |
Change
0.130(0.94%) |
Mkt cap ! $1.779B | |||
| Open | High | Low | Value | Volume |
| $13.66 | $14.03 | $13.46 | $11.10M | 803.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1608 | $13.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.99 | 250 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |